Thank you for signing up to the Anaphylaxis UK Business Newsletter! Keep an eye on your inbox each month for the need-to-know updates for your business.
The University of Manchester is inviting individuals to participate in an event where they can share their healthcare experiences and contribute to meaningful discussions with student researchers. This research opportunity aims to help students learn directly from patients about their
[…]
The National Institute for Health and Care Excellence (NICE) has released its final draft guidance, recommending Acarizax for NHS use in the management of house dust mite allergy. Developed by ALK-Abello, Acarizax is the first therapy specifically designed to treat
[…]
ARS Pharmaceuticals has made significant progress in expanding access to neffy®, its needle-free adrenaline (epinephrine) nasal spray. After gaining approval in the U.S. and Europe for treating severe allergic reactions like anaphylaxis, ARS Pharmaceuticals has now filed for approval in
[…]